News

1 to 9 of 95950 results

India's Piramal will divert resources from early-stage research to advanced-stage molecules

India's Piramal will divert resources from early-stage research to advanced-stage molecules

29-08-2014

Indian pharma company Piramal Enterprises has announced its intention to stop early-stage research in…

IndiaMetabolic disordersPharmaceuticalPiramal EnterprisesPiramal HealthcareProductionResearchSwati PiramalUS Food and Drug Administration

Minomic to reformulate its MIL-38 prostate cancer screening target as a therapy with Catalent

Minomic to reformulate its MIL-38 prostate cancer screening target as a therapy with Catalent

29-08-2014

Australian biotech company Minomic International will join forces with Catalent Pharma to develop its…

AustraliaBiotechnologyCatalent PharmaMinomicOncologyProstate cancerProstate cancer screening technologyResearch

Takeda's 10-year study finds no link between pioglitazone and bladder cancer

Takeda's 10-year study finds no link between pioglitazone and bladder cancer

29-08-2014

Japan’s largest drugmaker Takeda has completed the post-marketing commitment and data submissions to…

Bladder cancerEuropean Medicines AgencyJapanOncologyPharmaceuticalPioglitazoneRegulationResearchTakeda PharmaceuticalsUS Food and Drug Administration

Edison re-evaluates Onconova based on extended rigosertib timeline after trial failure

Edison re-evaluates Onconova based on extended rigosertib timeline after trial failure

29-08-2014

After failing to meet the primary endpoint of its trial of rigosertib (IV), oncology specialist Onconova…

FinancialMyelodysplastic syndromeOncologyOncology specialistOnconova TherapeuticsPharmaceuticalrigosertibUSA

Amgen files for US approval of cholesterol drug evolocumab

28-08-2014

USA-based Amgen, the world's leading independent biotech firm, has filed a Biologics License Application…

AmgenBiotechnologyCardio-vascularevolocumabRegulationUSA

Curious resilience of the $50,000-per-QALY threshold

28-08-2014

For more than two decades, the ratio of $50,000 per quality-adjusted life-year (QALY) gained by using…

HealthcarePharmaceuticalPricingRegulationUSA

Ebola vaccine trials fast-tracked by international consortium, including GSK

Ebola vaccine trials fast-tracked by international consortium, including GSK

28-08-2014

In the wake of the devastating outbreak of Ebola in West Africa, an unprecedented international consortium…

At preventing the diseaseBiologyDiseaseEbola epidemicGlaxoSmithKlineMedicinePharmaceuticalResearchTropical diseasesVaccines

Green Cross Neulapeg biosimilar approved in South Korea

28-08-2014

South Korea’s Green Cross says that the country’s Ministry of Food and Drug Safety has granted marketing…

AmgenAsia-PacificBiosimilarsBiotechnologyGreen CrossNeulapegNeulastaOncologyRegulation

1 to 9 of 95950 results

Back to top